{"disease":{"id":"significant-bowel-pathology","name":"significant bowel pathology"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07430540","title":"Optimising Colorectal Cancer Patient Pathways","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University of Edinburgh","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}